Germline SMARCE1 mutations predispose to both spinal and cranial clear cell meningiomas

Journal of Pathology

Volumn 234, Issue 4, 2014, Pages 436-440

  Smith, Miriam J ^a   Wallace, Andrew J ^a   Bennett, Chris ^b   Hasselblatt, Martin ^c   Elert Dobkowska, Ewelina ^d,e   Evans, Linton T ^f   Hickey, William F ^f   Van Hoff, Jack ^f   Bauer, David ^f   Lee, Amy ^g   Hevner, Robert F ^h   Beetz, Christian ^d   Du Plessis, Daniel ⁱ   Kilday, John Paul ^j   Newman, William G ^a   Evans, D Gareth ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHAPEL ALLERTON HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

^e INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^f DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^g SEATTLE CHILDREN S HOSPITAL   (United States)

^h SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

ⁱ HOPE HOSPITAL   (United Kingdom)

^j ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

more..

Author keywords

Clear cell; Meningioma; SMARCE1

Indexed keywords

PARAFFIN; PROTEIN; SMARCE1 PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCE1 PROTEIN, HUMAN;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; CRANIAL CLEAR CELL MENINGIOMA; EMBEDDING; FATHER; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENETIC PREDISPOSITION; GERMLINE MUTATION; HUMAN; MALE; MENINGIOMA; NONSENSE MUTATION; PHENOTYPE; POINT MUTATION; RELATIVE; SIBLING; SOMATIC MUTATION; SPINAL MENINGIOMA; BRAIN TUMOR; GENE DOSAGE; GENETICS; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PEDIGREE; PRESCHOOL CHILD; SPINAL CORD TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; PEDIGREE; SPINAL NEOPLASMS; YOUNG ADULT;

EID: 84910681433     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4427     Document Type: Article

References (13)

1. Mulvihill JJ, Parry DM, Sherman JL, et al. NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med 1990; 113: 39-52.
2. Wellenreuther R, Kraus JA, Lenartz D, et al. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995; 146: 827-832.
3. Lekanne Deprez RH, Bianchi AB, Groen NA, et al. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 1994; 54: 1022-1029.
4. Schmitz U, Mueller W, Weber M, et al. INI1 mutations in meningiomas at a potential hotspot in exon 9. Br J Cancer 2001; 84: 199-201.
5. Hadfield KD, Smith MJ, Trump D, et al. SMARCB1 mutations are not a common cause of multiple meningiomas. J Med Genet 2010; 47: 567-568.
6. Smith MJ, O'Sullivan J, Bhaskar SS, et al. Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas. Nat Genet 2013; 45: 295-298.
7. Aavikko M, Li SP, Saarinen S, et al. Loss of SUFU function in familial multiple meningioma. Am J Hum Genet 2012; 91: 520-526.
8. van den Munckhof P, Christiaans I, Kenter SB, et al. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri. Neurogenetics 2012; 13: 1-7.
9. Jagani Z, Mora-Blanco EL, Sansam CG, et al. Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway. Nat Med 2010; 16: 1429-1433.
10. Clark VE, Erson-Omay EZ, Serin A, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 2013; 339: 1077-1080.
11. Brastianos PK, Horowitz PM, Santagata S, et al. Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 2013; 45: 285-289.
12. Bauer P, Stevanin G, Beetz C, et al. Spinocerebellar ataxia type 11 (SCA11) is an uncommon cause of dominant ataxia among French and German kindreds. J Neurol Neurosurg Psychiat 2010; 81: 1229-1232.
13. Beetz C, Nygren AO, Schickel J, et al. High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 2006; 67: 1926-1930.